[1]杨金凯,谢佳希,范涛,等.扶正合剂治疗脾肺两虚型反复呼吸道感染患儿临床研究[J].陕西中医,2026,(3):345-349.[doi:DOI:10.3969/j.issn.1000-7369.2026.03.010]
　YANG Jinkai,XIE Jiaxi,FAN Tao,et al.Clinical research on Fuzheng mixture in the treatment of recurrent respiratory tract infections in children with deficiency of both spleen and lung[J].,2026,(3):345-349.[doi:DOI:10.3969/j.issn.1000-7369.2026.03.010]
点击复制

扶正合剂治疗脾肺两虚型反复呼吸道感染患儿临床研究

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2026年3期
页码:
345-349
栏目:
临床研究
出版日期:
2026-03-05

文章信息/Info

Title:
Clinical research on Fuzheng mixture in the treatment of recurrent respiratory tract infections in children with deficiency of both spleen and lung
作者:
杨金凯; 谢佳希; 范涛; 罗洁
（攀枝花市中西医结合医院 攀枝花学院附属医院儿科，四川 攀枝花 617000）
Author(s):
YANG Jinkai; XIE Jiaxi; FAN Tao; LUO Jie
（Department of Pediatrics,Panzhihua Hospital of Integrated Traditional Chinese and Western Medicine，Affiliated Hospital of Panzhihua University,Panzhihua 617000,China）
关键词:
反复呼吸道感染; 脾肺两虚型; 扶正合剂; 中医证候积分; 免疫球蛋白A; 免疫球蛋白M; 免疫球蛋白G
Keywords:
Recurrent respiratory tract infections; Deficiency of both spleen and lung type; Fuzheng mixture; TCM syndrome points; Immunoglobulin A; Immunoglobulin M; Immunoglobulin G
分类号:
R 725.6
DOI:
DOI:10.3969/j.issn.1000-7369.2026.03.010
文献标志码:
A
摘要:
目的：探讨扶正合剂治疗脾肺两虚型反复呼吸道感染（RRTI）患儿的疗效以及对中医证候积分、血清因子及免疫功能的影响。方法：按照随机数字表法将120例小儿脾肺两虚型RRTI患儿分为对照组（60例，给予泛福舒治疗）和试验组（60例，给予泛福舒联合扶正合剂治疗）。观察治疗后两组疗效、临床症状消失所需时长，记录两组治疗前、后中医症候积分、血清因子、免疫功能，比较不良反应。结果：治疗前，两组反复感冒、恶寒、不耐寒凉、动则汗出、面色萎黄、咳嗽无力、食欲不振、脘腹胀满、瘦弱评分，临床症状消失所需时长，血清因子水平及免疫功能水平比较差异无统计学意义（P＞0.05）；与治疗前比较，治疗后两组反复感冒、恶寒、不耐寒凉、动则汗出、面色萎黄、咳嗽无力、食欲不振、脘腹胀满、瘦弱评分，临床症状消失所需时长，血清因子水平及免疫功能水平均明显改善；与对照组比较，试验组反复感冒、恶寒、不耐寒凉、动则汗出、面色萎黄、咳嗽无力、食欲不振、脘腹胀满、瘦弱评分，临床症状消失所需时长，血清因子水平及免疫功能水平改善更明显，且疗效更高，不良反应更低（P＜0.05）。结论：小儿脾肺两虚型RRTI患儿采用扶正合剂治疗，可缓解相关临床症状，降低中医症候积分，缩短临床症状消失时间，值得在临床应用。
Abstract:
Objective:This study aims to explore the efficacy of Fuzheng mixture in the treatment of children with recurrent respiratory tract infection (RRTI) due to deficiency of both spleen and lung,as well as its influence on TCM syndrome score,serum factors and immune function.Methods:According to the random number table method,120 children with RRTI of spleen and lung deficiency type were divided into the control group (60 cases,treated with Panfushu) and the experimental group (60 cases,treated with Panfushu combined with Fuzheng mixture).Observe the therapeutic effects of the two groups after treatment,the time required for the disappearance of clinical symptoms,record the TCM syndrome scores,serum factors and immune functions of the two groups before and after treatment,and compare adverse reactions.Results:Before treatment,the scores of repeated colds,chills,intolerance to cold,sweating upon movement,sallow complexion,weak cough,loss of appetite,distension and fullness in the epigastrium and abdomen,emaciation,the time required for the disappearance of clinical symptoms,serum factor levels and immune function levels were compared between the two groups (P>0.05).After treatment,compared with before treatment,the scores of repeated colds,chills,intolerance to cold,sweating upon movement,sallow complexion,weak cough,loss of appetite,distension and fullness in the epigastrium and abdomen,emaciation,the time required for the disappearance of clinical symptoms,serum factor levels and immune function levels in both groups were significantly improved.Compared with the control group,the experimental group showed more significant improvements in the scores of repeated colds,chills,intolerance to cold,sweating with physical activity,sallow complexion,weak cough,loss of appetite,distension and fullness in the epigastrium and abdomen,emaciation,the time required for the disappearance of clinical symptoms,serum factor levels and immune function levels,and had higher therapeutic effects and lower adverse reactions (P<0.05).Conclusion:For children with RRTI due to deficiency of both spleen and lung,the treatment with Fuzheng mixture can alleviate related clinical symptoms,reduce the TCM syndrome score,and shorten the disappearance time of clinical symptoms.It is worthy of clinical promotion and application.

参考文献/References:

[1]史艳平,张金虎,张敏涛,等.陕西省2023年冬季儿童急性呼吸道感染性疾病中医药防治方案 [J].陕西中医,2024,45(1):3-7.
[2]王博佳,朱蔓,鲍习奎,等.邱根祥教授基于雷氏“伏邪理论”治疗小儿反复呼吸道感染经验[J].中医儿科杂志,2025,21(2):22-25.
[3]王芳,刘韬,徐志强,等.宣肺健脾推拿联合玉屏风颗粒治疗小儿反复呼吸道感染的临床研究[J].中医药导报,2025,31(5):103-106.
[4]谢军,张溪,李昌林.基于肠黏膜屏障修复中医药治疗溃疡性结肠炎研究进展[J].辽宁中医药大学学报,2025,27(6):177-182.
[5]闫晓云.固卫防感膏对肺脾气虚型小儿反复呼吸道感染的治疗效果及对免疫球蛋白的影响[J].中外医疗,2025,44(7):137-140.
[6]郑雪玲.扶正固本抗感方与西药联合治疗小儿反复上呼吸道感染的疗效观察及对细胞免疫的影响[J].中国防痨杂志,2024,46(S2):184-186.
[7]温振英,郑军.小儿体质类型与辨证论治[J].中医杂志,1998,39(6):362-363.
[8]张波.反复呼吸道感染的临床概念和处理原则[J].世界最新医学信息文摘,2017,17(12):194.
[9]国家食品药品监督管理局.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:224-226.
[10]莫珊,蔡靖宜,吴声振,等.健脾补肺膏联合天灸对脾肺气虚型小儿反复呼吸道感染患者的临床疗效[J].中成药,2023,45(6):2102-2104.
[11]王宁,史正刚,葛坤祖,等.张士卿教授运用培土生金法治疗小儿反复呼吸道感染经验[J].中医临床研究,2023,15(16):134-136.
[12]王秋莉,刘应科,杨晔,等.宣肺运脾方辅助西药治疗儿童哮喘并发反复呼吸道感染临床研究 [J].陕西中医,2024,45(10):1357-1360.
[13]史文乐,岳淼.Graves病患者上呼吸道感染后TRAb水平变化及甲状腺功能紊乱研究 [J].陕西医学杂志,2025,54(6):790-793.
[14]李彬,顾晔,徐强,等.中医推拿防治小儿脾肺气虚型反复呼吸道感染的临床效果[J].山西医药杂志,2020,49(11):1365-1366.
[15]夏天,傅剑萍,唐宏亮,等.推拿防治小儿脾肺气虚型反复呼吸道感染的临床观察[J].南京中医药大学学报,2018,34(3):273-276.
[16]王杨广,麦景亮,张建平.布地格福联合泛福舒改善稳定期COPD患者肺功能的临床研究[J].海南医学,2023,34(21):3074-3077.
[17]于瑞杰,武静.白细胞计数、C反应蛋白及淋巴细胞与单核细胞比值预测细菌性下呼吸道感染的临床价值[J].临床医学研究与实践,2025,10(21):35-38，55.
[18]刘晶,杨英.血清CysLTs、KL-6、S100A2水平与呼吸道合胞病毒感染患儿病情严重程度的相关性分析[J].国际检验医学杂志,2025,46(4):506-509.
[19]李富云,南丽丽,杨锡仓,等.党参化学成分、药理作用及质量控制研究进展[J].甘肃中医药大学学报,2024,41(5):79-83.
[20]杨田义,孙乐.白术炮制规格及其化学成分与药理作用研究进展[J].中国实用医药,2024,19(13):174-177.
[21]何鹏飞,高敏,文继红,等.茯苓药理作用研究进展[J].云南中医中药杂志,2024,45(8):83-87.
[22]吕黎明,张来宾,吕洁丽.茯苓的化学成分、药理作用及临床应用[J].滨州医学院学报,2024,47(1):61-67.
[23]柴彦群,毛迪,柴艳平.桔梗皂苷D防治肺部疾病的药理作用研究进展[J].现代药物与临床,2024,39(11):2996-3000.
[24]杨思雨,史汶龙,路平,等.枳实化学成分及药理作用研究进展[J].中成药,2023,45(7):2292-2299.
[25]肖雨,唐晶,邓璐璐.反复呼吸道感染患儿维生素A、维生素D、维生素E水平与免疫功能的关系[J].保健医学研究与实践,2024,21(S1):145-148.
[26]郑莉,张阳,杨扬.反复呼吸道感染患儿血清沉默信息调节因子2相关酶1和高迁移率族蛋白B1水平与免疫功能的横断面分析[J].传染病信息,2025,38(3):246-250.
[27]刘柯,贾淑红,丁军颖.黄芪甲苷对炎性巨噬细胞RAW264.7的免疫调控及其机制探讨[J].免疫学杂志,2024,40(7):555-560.
[28]ZHOU X,LIU Z,LONG T,et al.Immunomodulatory effects of herbalformula of astragalus polysaccharide(APS)and polysaccharopeptide(PSP)in micewith lung cancer[J].Int J Biol Macromol,2018，10(61):596-601.
[29]厉晓,龚婕,丁婵,等.茯苓多糖的结构、活性及其构效关系研究进展[J].中草药,2025,56(1):305-317.

相似文献/References:

[1]陈庆庆,张 骠.张骠教授治疗小儿反复呼吸道感染经验[J].陕西中医,2019,(7):940.
　CHEN Qingqing,ZHANG Biao..Professor Zhang Biao in the treatment of Children’s recurrent respiratory tract infections[J].,2019,(3):940.

备注/Memo

备注/Memo:
四川省医学会医学科研青年创新课题（Q21035）;四川省攀枝花市指导性科技计划项目（2023ZD-S-19）
更新日期/Last Update: 2026-03-05